| HOME >> BIOLOGY >> TECHNOLOGY |
PARIS, July 3, 2012 /PRNewswire/ --
Genomic Vision, a leading biotechnology company specializing in developing genetic diagnostic tests using DNA molecular combing, is announcing the extension of its intellectual property portfolio, with the granting in several countries of a patent on an innovative method of structural and visual analysis of the genome, called Genomic Morse Code (GMC).
(Photo: http://photos.prnewswire.com/prnh/20120702/542983 )
"This new patent is in line with a solid portfolio of patents covering molecular combing, for which Genomic Vision holds the exclusive world license. With the GMC patent, the first of its own patents, Genomic Vision is strengthening its competitive edge and demonstrating its innovative force," says Aaron Bensimon, CEO of Genomic Vision.
The molecular combing technology allows direct microscopic visualization of large genomic regions using fluorescent markers. They form patterns specific to genomic locations using a limited number of colors, a little like traditional Morse Code, hence the name Genomic Morse Code.
Example of the gene for the genetic predisposition to cancer BRCA1. Image acquisition and analysis remain sufficiently simple thanks to the limited number of colors. Since pattern recognition is based on the size, spacing and color of several markers, the combinations are infinite, allowing for the coverage of any number of genes. Rearrangements are readily identified as modifications in the expected pattern. Photo credit: Genomic Vision©.
High-resolution technology on single DNA molecules
Genomic Morse Code is the key to diagnostics applications that make use of this high resolution, single DNA molecule technology.
"Genomic Vision developed the GMC strategy in its effort to develop
'/>"/>
| SOURCE Genomic Vision Copyright©2012 PR Newswire. All rights reserved |